Summary: Ménière’s disease is a chronic and often disabling inner ear disorder that affects roughly one in 2,000 people. It is marked by sudden, severe episodes of vertigo, fluctuating sensorineural hearing loss, persistent tinnitus (perception of ringing, buzzing, or other sounds in the ear), and a sensation of fullness or pressure in the affected ear. Traditionally, clinicians have focused on fluid imbalance or pressure buildup in the inner ear as the central cause, but the underlying origins have remained unclear.
A new, large-scale genetic study has shifted that view. By analyzing genetic data from nearly two million people, researchers uncovered strong evidence that Ménière’s disease is tied in part to subtle genetic differences that shape the inner ear’s development early in life—possibly before birth. These developmental variations appear to create a structural vulnerability that makes some people more likely to develop symptoms later in life when exposed to triggers such as aging, vascular changes, inflammation, or other environmental stresses.
Key Facts
- Unprecedented scale: The analysis pooled data from five major biobank projects, assembling 8,969 clinically identified Ménière’s cases and nearly two million controls to maximize statistical power.
- Five genomic risk loci: The study identified five independent regions of the genome associated with increased risk for Ménière’s disease.
- Developmental blueprint model: Findings support a model in which small, common genetic variants influence the inner ear’s developmental program, producing subtle anatomical differences that increase lifetime vulnerability.
- Retinoic acid (vitamin A) pathway implicated: Risk signals were found near genes that regulate retinoic acid, a vitamin A derivative essential for embryonic organ formation and adult fluid-pressure regulation, linking developmental and fluid-balance hypotheses.
- Shared genetic architecture: Ménière’s disease shows genetic overlap with conditions such as migraine, tinnitus, vertigo, hearing loss, and sleep apnea, indicating related biological mechanisms.
Source: University of Pennsylvania
Using nearly two million genomes to rethink Ménière’s disease
A research team at the Perelman School of Medicine, University of Pennsylvania, reporting in the American Journal of Human Genetics, performed the largest genome-wide meta-analysis to date for Ménière’s disease. Their work provides new genetic evidence that risk for the disorder partly stems from genes that guide inner ear development. Rather than arising only from adult-onset fluid accumulation, the condition may reflect lifelong susceptibility rooted in early structural differences.
Clinically, Ménière’s disease presents with recurrent attacks of vertigo, unpredictable fluctuations in hearing, persistent tinnitus, and a feeling of ear fullness. Historically, endolymphatic hydrops—abnormal fluid accumulation in the inner ear—was the dominant explanatory model. The new genetic findings establish a framework that connects that fluid imbalance model with developmental biology: genes active during early formation of the cochlea and vestibular apparatus may influence how effectively the ear maintains fluid and pressure balance throughout life.
“Our results indicate that Ménière’s disease risk is influenced by how the inner ear is formed early on,” said Douglas Epstein, PhD, vice chair of Genetics at Penn and senior co-author. “These developmental differences are generally subtle, falling within normal variation, but they can render the ear more susceptible to dysfunction decades later.”
Biobank-driven discoveries
The study integrated genetic and health-record data from five major biobanks—collectively covering diverse populations and large sample sizes—including nearly 9,000 affected individuals and almost 2 million controls. Analysis pinpointed five genome-wide significant loci, including signals near genes involved in inner ear development and retinoic acid metabolism. Two additional loci showed strong, near-significant associations that warrant further study.
Why retinoic acid matters
Retinoic acid, derived from vitamin A, functions as a crucial signaling molecule during embryonic organ development and later helps regulate cellular processes that influence fluid balance. The presence of genetic associations near retinoic acid–related genes suggests this pathway could link developmental structure to adult fluid regulation, unifying older ideas about endolymphatic hydrops with new developmental insights.
“Identifying these biological pathways gives researchers clearer targets to investigate in laboratory models,” said Bogdan Pasaniuc, PhD, a senior co-author. “This study narrows the search to specific genes and processes that are likely important for ear structure and pressure control.”
Implications and next steps
Although the genetic contribution detected is meaningful, common variants explain only a modest portion of overall risk—about 7 percent—so genetic testing cannot currently predict or diagnose Ménière’s disease. The principal value of the genetic map is guiding laboratory research: future work will use human inner ear models and animal experiments to determine how implicated genes change ear development, structure, and fluid homeostasis. Larger and more diverse genetic studies will refine these signals and explore potential clinical applications.
To translate these discoveries into better outcomes, the research team has initiated a translational partnership to explore preventive genomic sequencing and strategies aimed at early detection and equitable access to interventions for adult-onset hearing disorders.
Funding: This research was supported by the National Institute on Aging, the National Institute of Mental Health, the National Institute of General Medical Sciences, and the National Institute on Deafness and Other Communication Disorders.
Key Questions Answered:
A: The study moves the field beyond a focus solely on adult-onset fluid buildup. It suggests that small genetic differences influencing inner ear development may establish a structural predisposition long before symptoms appear. Those developmental differences, although subtle, can interact with aging and environmental factors to produce symptomatic disease in adulthood.
A: Retinoic acid is a signaling molecule derived from vitamin A that guides organ formation during embryogenesis and helps regulate physiological processes later in life, including aspects of fluid balance. Finding genetic signals near retinoic acid–related genes links developmental mechanisms to adult fluid regulation, providing a specific biological target for future research and potential therapies.
A: No. Current genetic findings account for only a small fraction of overall risk and are not sufficient for clinical prediction or diagnosis. The primary benefit of this research is to direct laboratory studies toward genes and pathways that could eventually inform treatments or prevention strategies.
Editorial Notes:
- This article was edited by a Neuroscience News editor.
- The original journal paper was reviewed in full.
- Additional context was added by the editorial staff.
About this genetics and Ménière disease research news
Author: Matthew Toal
Source: University of Pennsylvania
Contact: Matthew Toal – University of Pennsylvania
Image: Image credit: Neuroscience News
Original Research: Open access. “Genome-wide analysis implicates inner ear development in Ménière disease” by Zhuozheng Shi et al., American Journal of Human Genetics. DOI: 10.1016/j.ajhg.2026.05.011
Abstract
Genome-wide analysis implicates inner ear development in Ménière disease
Ménière disease is a chronic inner ear disorder with recurring vertigo, fluctuating sensorineural hearing loss, and tinnitus. To clarify its etiology, researchers conducted a genome-wide meta-analysis of 8,969 case subjects and 1,962,542 control subjects across five biobanks, identifying five independent genome-wide significant loci and estimating an observed-scale single nucleotide polymorphism (SNP) heritability of approximately 7% (SE 0.8%).
Significant signals included variants at EYA4 and EYA1, and a locus near CYP26A1, with effect sizes (odds ratios) ranging from about 1.1 to 1.25. Additional associations at LMO4 and ALDH1A2 fell just below genome-wide significance. Integrative analyses implicate two converging biological processes: developmental regulation of the inner ear (EYA4, EYA1, LMO4) and retinoic acid metabolism (CYP26A1/C1, ALDH1A2). These developmental regulators are expressed in both fetal and adult inner ear cell types, supporting a model in which altered developmental programs predispose individuals to auditory and vestibular dysfunction later in life.
Phenome-wide and genetic-correlation analyses reveal shared genetic architecture between Ménière disease and related traits—vertigo, tinnitus, hearing loss, migraine, and sleep apnea—placing Ménière disease within a broader spectrum of sensory and neurological disorders. Together, these findings provide a genetic framework implicating inner ear development and retinoic acid signaling as key contributors to disease risk.